Information Provided By:
Fly News Breaks for August 25, 2015
AXDX
Aug 25, 2015 | 06:53 EDT
BTIG upgraded Accelerate Diagnostics to Buy with a $28 price target. The firm upgraded shares based on valuation and said recent channel checks support management's comments on progress being made for gaining FDA approval.